Abstract 5338: TY-1781, a potent and highly selective CDK2 inhibitor, demonstrates superior anti-tumor activity in CCNE1 high-expression solid tumor models

Authors: Chengshan Niu, Meihua Li, Shaoqing Chen, Maolin Zheng, Mingtao Chen, Hui Xu, Kaige Ji, Yuanjie Li, Rui Wu, Shengli Dong, Yu Yu, Xinlong Yang, Chao Zhou, Apeng Liang, Wei Wu, Mingyu Jiang, Jun Li, Yusheng Wu

Published: 2025-04-21

DOI: 10.1158/1538-7445.am2025-5338

Source: Full article


Abstract

Abstract